Article

Modafinil Shakes Patients from Thalamic Infarction Lethargy

Author(s):

In a striking case report, the stimulant modafinil was able to dramatically improve neurological functioning in an elderly woman suffering from bilateral thalamic infarction, a disorder that often is fatal.

In a striking case report, the stimulant modafinil was able to dramatically improve neurological functioning in an elderly woman suffering from bilateral thalamic infarction, a disorder that often is fatal.

“This woman slept for long hours and even when she was awake, she was very lethargic,” said Kristina Darnauer, MD, a resident in family practice at the Research Medical Center, Kansas City, MO.

Lethargy, extended sleep, sleepiness and coma often occur in patients with bilateral thalamic infarction caused by hypoperfusion of the thalamo-perforating arteries, explained Dr. Darnauer at her poster “Bilateral Thalamic Infarction Treatment with Modafinil,” presented at the 61st Annual Meeting of the American Academy of Neurology.

The disorder interferes with the body’s arousal on switch. “People go to sleep, and they just don’t wake up,” Dr. Darnauer said. The condition results in a high degree of mortality and morbidity from stupor and coma.

In the case she presented, an 82-year-old woman was hospitalized after being observed in a stuporous condition for two days. The women had a history of diabetes, hypertension, and peripheral artery disease, but her serum chemistries and arterial blood chemistries were normal. A magnetic resonance imaging study detected acute infarction of the medial thalamus.

On the third day of hospitalization, doctors began administering modafinil. “In the next few days, the patient showed improvement,” Dr. Darnauer said. “She was able to stay awake, engage in conversations, and became independent in all her activities of daily living.”

The treatment appears to be necessary for normal functioning, she said. “At one point, the woman did not receive modafinil for two days and she reverted back to deep stupor,” Dr. Darnauer said. When modafinil was re-instituted, the woman recovered.

She said the cause of bilateral thalamic infarction is basically due to atherosclerosis/embolism in the vertebro-basilar system. The thalamo-perforating arteries are branches of the vertebro-basilar arteries. “The clinical phenomenon may vary by the location of the infarction,” she said, “but somnolence is invariably present. Hypersomnolence is mediated by damage to common pathways of arousal that traverse through the thalamus.

“Drugs such as modafinil and other stimulants causes wakefulness through the intricate adrenergic/hypocritin system, and can result in meaningful recovery,” she added.

The cerebrovascular accidents that create bilateral thalamic infarction are rare events, Dr. Darnauer said. “However, with treatment the sleep/wake cycle can be normalized, resulting in better neurological and functional outcomes.”

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.